The C-POST trial showed a disease-free survival benefit with adjuvant Libtayo for high-risk cutaneous squamous cell carcinoma, potentially influencing future standard care. Immunotherapy remains the ...

Add Yahoo as a preferred source to see more of our stories on Google. Skin cancer is the most common cancer in the U.S., according to the Centers for Disease Control and Prevention. Between 1982 and ...

Whether it's rapidly growing spot or a red, angry-looking bump that won't go away, noticing any new or unusual changes on your skin usually raises a few red flags. Is it a pimple, a mole or at worst, ...

Older adults face unique risks for skin cancer due to long-term sun exposure and age-related changes. Skin cancer is becoming more common in older adult populations around the world. According to the ...

Checking your skin for signs of skin cancer can be lifesaving. It's a common misbelief that only people with light skin ...

Oily vs dry skin: Learn from a specialist if your skin type can make you more vulnerable to skin cancer.

Sunscreen can protect your skin, but as temperatures rise, should we look to European approaches to stay safer during the ...

Born and raised in Pittsburgh, Pennsylvania, weather has been a passion for Adam for as long as he can remember! Whether it was thunderstorms or winter storms, Adam has always been geeking out. After ...

Merck is the pharmaceutical company that makes a medication called pembrolizumab (Keytruda), which is used to treat different ...